From the Research
The annexin market is expected to grow significantly, driven by the increasing use of annexin V in research and clinical settings, as well as the potential of annexins in diagnostics, therapeutics, and research applications, as supported by the most recent study in 2021 1. The annexin market is a growing segment within the biotechnology and pharmaceutical industries, focusing on proteins that bind to phospholipids in a calcium-dependent manner. Annexins have significant potential in diagnostics, therapeutics, and research applications. Currently, the market is primarily driven by annexin V, which is widely used to detect apoptosis (programmed cell death) in research and clinical settings. Companies like BioVision, Abcam, and BD Biosciences offer annexin V kits for flow cytometry and imaging applications. Some key points to consider in the annexin market include:
- The use of annexin V in detecting apoptosis, as described in a study from 1998 2
- The potential of annexins in treating inflammatory diseases, cardiovascular disorders, and cancer, as discussed in a study from 2010 3
- The importance of optimal timing for imaging apoptosis, as highlighted in a study from 2004 4
- The influence of cell harvesting methods on apoptosis analysis by annexin V staining, as investigated in a study from 2013 5
- The use of annexin V-based optical imaging and 18F-FDG-PET/CT in assessing apoptosis and glucose metabolism in lung cancer xenografts, as demonstrated in the most recent study from 2021 1 The most recent study from 2021 1 provides the strongest evidence for the growth and potential of the annexin market, and its findings should be prioritized in decision-making.